STI-2099 (COVI-DROPS)

STI-2099 · Sorrento Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for STI-2099 (COVI-DROPS), covering 2022-02-03 to 2022-02-03. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate a Single Intranasal Dose of STI-2099 (COVI-DROPS™) in Outpatient Adults With COVID-19 (US) [Phase 2]

See pricing